Citation Tools
PDFRegular and Young Investigator Award Abstracts
Clinical Trials In Progress
659 COM701 plus nivolumab demonstrates preliminary antitumor activity and immune modulation of tumor microenvironment in patients with metastatic MSS-CRC and liver metastases
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 659 COM701 plus nivolumab demonstrates preliminary antitumor activity and immune modulation of tumor microenvironment in patients with metastatic MSS-CRC and liver metastases